Literature DB >> 25387185

Quality and costs of end-of-life care: the need for transparency and accountability.

Joan M Teno1, Pedro L Gozalo1.   

Abstract

Mesh：

Year:  2014        PMID： 25387185     DOI： 10.1001/jama.2014.14949

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Contextualizing the use of oncologic imaging within treatment phases: imaging trends and modality preferences, 2000-2014.

Authors:  T P Copeland; J M Creasman; D J Seidenwurm; B L Franc
Journal:  Curr Oncol       Date:  2017-04-27       Impact factor: 3.677

2.  Trends in end-of-life cancer care in the Medicare program.

Authors:  Shi-Yi Wang; Jane Hall; Craig E Pollack; Kerin Adelson; Elizabeth H Bradley; Jessica B Long; Cary P Gross
Journal:  J Geriatr Oncol       Date:  2016-01-15       Impact factor: 3.599

3.  Palliative care and imaging utilisation for patients with cancer.

Authors:  Kesav Raghavan; Timothy P Copeland; Michael Rabow; Maya Ladenheim; Angela Marks; Steven Z Pantilat; David O'Riordan; David Seidenwurm; Benjamin Franc
Journal:  BMJ Support Palliat Care       Date:  2019-03-01       Impact factor: 3.568

4.  End-of-Life Care Intensity and Hospice Use: A Regional-level Analysis.

Authors:  Shi-Yi Wang; Melissa D Aldridge; Cary P Gross; Maureen Canavan; Emily Cherlin; Rosemary Johnson-Hurzeler; Elizabeth Bradley
Journal:  Med Care       Date:  2016-07       Impact factor: 2.983

5.  The Impact of Hospice Care on Survival and Healthcare Costs for Patients with Lung Cancer: A National Longitudinal Population-Based Study in Taiwan.

Authors:  Jui-Kun Chiang; Yee-Hsin Kao; Ning-Sheng Lai
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

6.  Introducing the trajectory Touchpoint technique: a systematic methodology for capturing the service experiences of palliative care patients and their families.

Authors:  Lynn Sudbury-Riley; Philippa Hunter-Jones; Ahmed Al-Abdin
Journal:  BMC Palliat Care       Date:  2020-07-10       Impact factor: 3.234
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.